HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SKAP associates with kinetochores and promotes the metaphase-to-anaphase transition.

Abstract
The spindle assembly checkpoint (SAC) controls the anaphase onset by preventing premature chromosome segregation until bipolar microtubule (MT) attachment and inter-kinetochore tension are fully established for every kinetochore pair. Once the SAC is off, activation of the Anaphase-Promoting Complex/Cyclosome, a ubiquitin ligase, leads to the degradation of securin and cyclin B, the activation of separase and the initiation of anaphase. We report here the identification and characterization of a G(2)-induced gene, SKAP, as a regulator for the anaphase onset. SKAP localizes to spindle MTs and kinetochores in mitosis. Depletion of SKAP does not activate the SAC, but substantially increases the duration of metaphase, delays the activation of separase, and decreases the fidelity of chromosome segregation. Our study identifies SKAP as a novel regulator of the metaphase-to-anaphase transition and demonstrates that misregulation of the separase activation results in a reduced fidelity of chromosome segregation and a reduced genomic stability independent of the SAC.
AuthorsLin Fang, Akiko Seki, Guowei Fang
JournalCell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 8 Issue 17 Pg. 2819-27 (Sep 01 2009) ISSN: 1551-4005 [Electronic] United States
PMID19667759 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphoproteins
  • RNA, Small Interfering
  • SKAP1 protein, human
Topics
  • Anaphase
  • Cell Differentiation
  • Cell Line, Tumor
  • Chromosome Segregation
  • G2 Phase
  • HeLa Cells
  • Humans
  • Kinetochores (metabolism)
  • Metaphase
  • Mitosis
  • Phosphoproteins (analysis, genetics, metabolism)
  • RNA, Small Interfering (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: